Cesca Therapeutics (KOOL) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts KOOL Hot Sheet
Price: $14.67 -0.27%
Financial Fact:
Total operating expenses: 3.33M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Total operating expenses: 3.33M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Cesca Therapeutics (NASDAQ: KOOL) reported Q1 EPS of ($0.08), versus ($0.14) reported last year. Revenue for the quarter came in at $3.7 million, versus $3.6 million reported last year.
For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Cosmos Health posts 29% revenue rise but widens net loss in Q2 2026
- Stifel Positive on Viking Holdings (VIK) Earnings: '2027 Booking Curves Continue To Show Strength'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
